Article: Managing adult asthma during the COVID-19 pandemic: A 2022 review and current recommendations.
Annals of the Academy of Medicine, Singapore
2022 Volume 51, Issue 10, Page(s) 637–647
Abstract: Introduction: This review aims to examine asthma management during the COVID-19 pandemic.: Method: Relevant recommendations and articles were identified by respiratory professional societies and PubMed search using the terms "asthma" and "COVID-19", ... ...
Abstract | Introduction: This review aims to examine asthma management during the COVID-19 pandemic. Method: Relevant recommendations and articles were identified by respiratory professional societies and PubMed search using the terms "asthma" and "COVID-19", and examined for relevance and inclusion in this study. Results: Recommendations for the management of asthma have remained similar but are now supported by new evidence between the years 2020 and 2022. Patients with well-controlled, mild-to-moderate asthma are unlikely to be at increased risk of acquiring COVID-19 or having worse outcomes from COVID-19. All asthma patients should receive COVID-19 vaccination. Spirometry can be performed with the usual strict infection control procedures unless there is a suspicion of COVID-19. Mask-wearing and other health measures remain important for asthma patients. Conclusion: While previous recommendations were largely based on expert opinion, the tremendous amount of literature published since the pandemic first emerged 2 years ago has helped guide respiratory professional bodies to update their recommendations. This study provides a timely review of the various recommendations and can be used to guide healthcare professionals in managing asthma patients, as the world prepares for a future with COVID-19 becoming endemic. The long-term consequences of COVID-19 infection in asthma patients and the ripple effects of COVID-19 remain uncertain and deserve ongoing study. |
---|---|
MeSH term(s) | Adult ; Humans ; COVID-19 ; Pandemics/prevention & control ; COVID-19 Vaccines ; Asthma/therapy ; Asthma/epidemiology ; Infection Control |
Chemical Substances | COVID-19 Vaccines |
Language | English |
Publishing date | 2022-08-08 |
Publishing country | Singapore |
Document type | Review ; Journal Article |
ZDB-ID | 604527-3 |
ISSN | 0304-4602 |
ISSN | 0304-4602 |
DOI | 10.47102/annals-acadmedsg.202285 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
Zs.B 2420: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.